
Inviragen’s DENVax, dengue vaccine, enters second stage of an ongoing Phase 2 study
Fort Collins, Colorado vaccine company, Inviragen, announced this week that it is advancing it’s investigational dengue vaccine, DENVax into the second stage of the ongoing Phase 2 clinical study, according More...